» Articles » PMID: 37488110

Associations of Cardiovascular Risk Factors and Lifestyle Behaviors with Neurodegenerative Disease: a Mendelian Randomization Study

Overview
Date 2023 Jul 24
PMID 37488110
Authors
Affiliations
Soon will be listed here.
Abstract

Previous observational studies reported that midlife clustering of cardiovascular risk factors and lifestyle behaviors were associated with neurodegenerative disease; however, these findings might be biased by confounding and reverse causality. This study aimed to investigate the causal associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease, using the two-sample Mendelian randomization design. Genetic variants for the modifiable risk factors and neurodegenerative disease were extracted from large-scale genome-wide association studies. The inverse-variance weighted method was used as the main analysis method, and MR-Egger regression and leave-one-out analyses were performed to identify potential violations. Genetically predicted diastolic blood pressure (DBP: OR per 1 mmHg, 0.990 [0.979-1.000]), body mass index (BMI: OR per 1 SD, 0.880 [0.825-0.939]), and educational level (OR per 1 SD, 0.698 [0.602-0.810]) were associated with lower risk of late-onset Alzheimer's disease (LOAD), while genetically predicted low-density lipoprotein (LDL: OR per 1 SD, 1.302 [1.066-1.590]) might increase LOAD risk. Genetically predicted exposures (including LDL and BMI) applied to familial AD showed the same effect. The association of LDL was also found with Amyotrophic lateral sclerosis (ALS) (LDL: OR per 1 SD, 1.180 [1.080-1.289]). This MR analysis showed that LDL, BMI, BP, and educational level were causally related to AD; a significant association between LDL and ALS risk, as well as the potential effect of sleep duration on PD risk, were also revealed. Targeting these modifiable factors was a promising strategy of neurodegenerative disease prevention.

Citing Articles

Is the Relationship Between Cardiovascular Disease and Alzheimer's Disease Genetic? A Scoping Review.

Moore A, Ritchie M Genes (Basel). 2025; 15(12).

PMID: 39766777 PMC: 11675426. DOI: 10.3390/genes15121509.


Mediterranean Diet Modulation of Neuroinflammation-Related Genes in Elderly Adults at High Cardiovascular Risk.

Hernando-Redondo J, Malcampo M, Perez-Vega K, Paz-Graniel I, Martinez-Gonzalez M, Corella D Nutrients. 2024; 16(18).

PMID: 39339745 PMC: 11434799. DOI: 10.3390/nu16183147.


The role of rs671 polymorphism and C-reactive protein in the phenotypes of male ALS patients.

Huang L, Liu M, Tang J, Gong Z, Li Z, Yang Y Front Neurosci. 2024; 18:1397991.

PMID: 39290715 PMC: 11405379. DOI: 10.3389/fnins.2024.1397991.


Association between "weekend warrior" physical activity and the incidence of neurodegenerative diseases.

Ning Y, Chen M, An J, Tang M, Tse G, Chan J Neurotherapeutics. 2024; 21(5):e00430.

PMID: 39129094 PMC: 11579868. DOI: 10.1016/j.neurot.2024.e00430.


Investigation of the Circular Transcriptome in Alzheimer's Disease Brain.

Gao Y, Xu S, Cheng Y, Takenaka K, Lindner G, Janitz M J Mol Neurosci. 2024; 74(3):64.

PMID: 38981928 PMC: 11233389. DOI: 10.1007/s12031-024-02236-0.


References
1.
Richardson T, Harrison S, Hemani G, Davey Smith G . An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. Elife. 2019; 8. PMC: 6400585. DOI: 10.7554/eLife.43657. View

2.
Huang J, Zuber V, Matthews P, Elliott P, Tzoulaki J, Dehghan A . Sleep, major depressive disorder, and Alzheimer disease: A Mendelian randomization study. Neurology. 2020; 95(14):e1963-e1970. PMC: 7682841. DOI: 10.1212/WNL.0000000000010463. View

3.
Broce I, Tan C, Fan C, Jansen I, Savage J, Witoelar A . Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathol. 2018; 137(2):209-226. PMC: 6358498. DOI: 10.1007/s00401-018-1928-6. View

4.
Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W . Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017; 81(5):718-728. DOI: 10.1002/ana.24936. View

5.
Ashok A, Andrabi S, Mansoor S, Kuang Y, Kwon B, Labhasetwar V . Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants (Basel). 2022; 11(2). PMC: 8869281. DOI: 10.3390/antiox11020408. View